Form D filings with the SEC list David Belitz as an Executive Officer and Promoter for Solas BioVentures Emerging Healthcare Fund. See sector focus.
Form D filings with the SEC list David Belitz as an Executive Officer and Promoter for Solas BioVentures Emerging Healthcare Fund. One Form D filing is on record, naming Solas BioVentures Emerging Healthcare Fund, LP. The SEC industry group for this offering is Pooled Investment Fund. The minimum investment accepted for this offering is $1,000,000. The issuer address on file is Chattanooga.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Chattanooga.
Investors like David Belitz · Full investor directory · Investor access · Company funding database